Delivery Order 36F79718D0524-36C24825N0404
Award Date
2/5/25
Potential Completion Date
2/4/26
Potential Value
$97K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Veracyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $77,295.91 firm fixed price delivery order contract to Veracyte, Inc., a for-profit organization, to provide the AFIRMA Thyroid Genomic Classifier (GEC) test. This test analyzes gene expression patterns in thyroid biopsy samples to aid in diagnosis and treatment planning. The contract was issued without a set-aside and has a period of performance through November 4, 2022. Veracyte has also been awarded an Indefinite Delivery Indefinite...
This is a $512,000.00 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, is for the provision of specialized genomic testing services, primarily focused on cancer diagnostics, to the VA's Veterans Integrated Service Network (VISN) 17. Veracyte has been awarded numerous contracts by the VA and Department of Defense to...
This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
This firm fixed-price federal contract, awarded by the Department of Veterans Affairs to Veracyte, Inc., provides specialty genomic laboratory testing services to support cancer detection and diagnosis efforts at VA medical facilities. The contract has a ceiling value of $353,303.84 and a performance period through July 15, 2026. Veracyte, a for-profit organization, will perform the work at its commercial laboratories. The contract is not set aside and is awarded under Veracyte's existing...
This is a firm fixed price, definitive contract awarded by the Veterans Integrated Service Network 16 of the U.S. Department of Veterans Affairs to Veracyte, Inc. for laboratory sample testing services. The contract has a ceiling value of $342,256.60 and a period of performance through December 31, 2025. Veracyte, Inc., a for-profit corporation, will provide genomic testing services to support cancer detection and diagnosis efforts, as well as differentiation of idiopathic pulmonary fibrosis, at...
This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs' Network Contracting Office 7 to Veracyte, Inc., a for-profit medical diagnostic company, for $697,200.00. The contract is for reference laboratory services, including thyroid molecular genomic sequencing diagnostics, such as the Afirma Genomic Sequencing Classifier (CPT code 81546) and Afirma Xpression Atlas (CPT code 0204U), to be provided to the Ralph H. Johnson VA Medical Center. The contract has a...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit corporation headquartered in South San Francisco, California. The contract, which is not set aside for any specific business category, is an Indefinite Delivery Vehicle (IDV) with a ceiling value of $58,000.00. It is for the provision of reference laboratory services for VISN 23. Veracyte, which specializes in advanced genomic testing...
This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the Department of Veterans Affairs (VA). The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) with a ceiling value of $112,200.00 for reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside and was awarded on May 1,...
This is a federal contract award by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a medical diagnostic company specializing in advanced genomic testing services. The contract is an Indefinite Delivery/Indefinite Quantity (IDIQ) with a ceiling value of $72,800.00 for providing reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. Veracyte will perform these testing...
This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....